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Dystonia, which causes intermittent or sustained abnormal postures and movements,
can present in a focal or a generalized manner. In the limbs, focal dystonia can occur in
either the upper or lower limbs and may be task-specific causing abnormal motor performance for only a specific task, such as in writer’s cramp, runner’s dystonia, or musician’s
dystonia. Focal limb dystonia can be non-task-specific and may, in some circumstances,
be associated with parkinsonian disorders. The true prevalence of focal limb dystonia
is not known and is likely currently underestimated, leaving a knowledge gap and an
opportunity for future research. The pathophysiology of focal limb dystonia shares some
commonalities with other dystonias with a loss of inhibition in the central nervous system
and a loss of the normal regulation of plasticity, called homeostatic plasticity. Functional
imaging studies revealed abnormalities in several anatomical networks that involve the
cortex, basal ganglia, and cerebellum. Further studies should focus on distinguishing
cause from effect in both physiology and imaging studies to permit focus on most relevant biological correlates of dystonia. There is no specific therapy for the treatment of
limb dystonia given the variability in presentation, but off-label botulinum toxin therapy is
Abbreviations: BOLD, blood oxygen level dependent; BoNT, botulinum neurotoxin; CSP, cortical silent period; DBS, deep
brain stimulation; DMN, default more network; fMRI, functional magnetic resonance imaging; GPi, globus pallidus interna;
LTP, long-term potentiation; M1, motor cortex; PAS, paired associative stimulation; PET, positron emission tomography; PMC,
premotor cortex; RD, runner’s dystonia; rTMS, repetitive transcranial magnetic stimulation; STDT, somatosensory temporal
discrimination threshold; tDCS, transcranial direct current stimulation; TMS, transcranial magnetic stimulation.
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often applied to focal limb and task-specific dystonia. Various rehabilitation techniques
have been applied and rehabilitation interventions may improve outcomes, but small
sample size and lack of direct comparisons between methods to evaluate comparative
efficacy limit conclusions. Finally, non-invasive and invasive therapeutic modalities have
been explored in small studies with design limitations that do not yet clearly provide
direction for larger clinical trials that could support new clinical therapies. Given these
gaps in our clinical, pathophysiologic, and therapeutic knowledge, we have identified
priorities for future research including: the development of diagnostic criteria for limb
dystonia, more precise phenotypic characterization and innovative clinical trial design
that considers clinical heterogeneity, and limited available number of participants.
Keywords: dystonia, limb, task-specific, research priorities, inhibition, deep brain stimulation, botulinum toxin

INTRODUCTION

such as abnormal flexion or extension of the fingers and may
be accompanied by abnormal wrist postures as well. It may not
always be possible, however, to differentiate between abnormal
posture as a manifestation of the dystonia and a compensatory
contraction or movement. In this regard, voluntary movement
of the contralateral (unaffected) hand may elicit the primary
dystonic posture in the affected hand. This is “mirror dystonia,”
which refers to a phenomenon in which voluntary movements
contralateral to the affected limb provoke dystonic movements
on the affected side (10, 11). For instance, in writer’s cramp when
writing with the unaffected non-dominant hand, the normal
voluntary movement can provoke or cause recapitulation of the
dystonic movements in the affected hand, even though it is not
engaged in the writing task. Assessing the abnormal posture in
the affected hand brought out by “mirror dystonia” may be helpful
in selecting the most appropriate muscles for botulinum toxin
(BoNT) injection.
Writer’s cramp has been described in the literature since 1830
and was originally classified as one of the “occupational neuroses”
(12). Gowers may have been the first to recognize the aspect of
“overuse” or repetitive action that typically precedes the development of the dystonic hand posture (12). He described that the
abnormal spasm initially occurred only with writing, but later
involved other actions—even affecting the non-dominant hand if
used for writing (12). Given the relationship to repetitive action,
writer’s cramp must be differentiated from overuse syndromes
and nerve entrapments (9). Sensory changes, in addition to pain
and weakness, may be helpful in identifying peripheral nerve
pathology rather than a dystonic etiology as a cause of the symptoms. In general, the remainder of the neurological exam should
be normal in writer’s cramp. If abnormalities are found, focal
structural lesions as well as neurodegenerative causes of dystonia
should be considered (Table 1).
Musician’s dystonia of the hand and arm is a focal task-specific
dystonia that classically affects performing artists at the peak of
their careers with an average age of onset at 36 years of age (13).
Musician’s dystonia can also affect the embouchure. This unusual
condition has afflicted famous musicians in the last two centuries,
including Robert Schumann, Leon Fleisher, Gary Graffman,
Peter Oundjian, and, likely, Yehudi Menuhin (14). Unlike all
other forms of focal dystonia, musician’s dystonia of the arm
has a striking male to female predilection at 4:1 with prevalence

The dystonias are a group of disorders characterized by sustained
or intermittent muscle contractions causing abnormal and often
repetitive movements, postures, or both (1, 2). Clinically the
dystonias are classified according to the area of the body that is
affected, their age at onset, temporal characteristics such as manner of onset or task specificity, and whether they are combined
with other neurological or medical features. Etiologically, they
are classified according to whether or not there is any associated
brain pathology or evidence for a genetic basis. In this review, we
will focus mainly on isolated limb dystonia that usually presents
in adult life, most commonly is of unknown origin, and can be
task-specific. We will summarize the current knowledge in the
areas of clinical features, pathophysiology, as well as current
therapeutic strategies. Then, we will identify priorities for future
research based on the knowledge gaps revealed.

CLINICAL FEATURES
Dystonia of the Upper Limb

In epidemiological studies conducted in different parts of the
world, the most commonly affected regions of the body include
the neck and craniofacial areas (3, 4). The upper limbs are the third
most commonly affected area, with estimated crude prevalence
rates of approximately 5–70 cases per million (3, 4). The majority
of upper limb dystonias first emerge in adulthood, with approximately 10–20% progressing to other body regions over 5–10 years
(5–7). Upper limb dystonias less commonly emerge in children;
although when they do present in children, there is greater risk of
progression to generalized dystonia (8). The commonly reported
features of upper limb dystonia include abnormal extension or
flexion of the wrist or fingers, pain in the hand or forearm, and
tremulous movements. Sometimes, there is pain in the hand or
forearm, but this is typically not a prominent symptom and may
be due to excessive muscular contraction.
In writer’s cramp, a task-specific upper limb dystonia, patients
initially report excessive tightness in hand or forearm muscles—
sometimes described as a “cramp” (9). Even though there may
be tightness, patients often can still perform the motor task, but
over time, motor performance degrades with variable loss of
dexterity, fatigue, or even pain. Abnormal postures can occur
Frontiers in Neurology | www.frontiersin.org
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among experts (19, 20). The lack of widely accepted diagnostic
criteria and reliable biomarkers for upper limb dystonias likely
contribute to the poor diagnostic recognition and agreement.
Although there are multiple reports describing the clinical
features for relatively large numbers of patients with cervical
dystonia and craniofacial dystonia, few address upper limb
dystonias. Most reports have included only relatively small numbers of patients with upper limb dystonia or they have focused
on specific subtypes, such as writer’s cramp (21–24), musician’s
dystonias (see below), or the dystonia associated with Parkinsonrelated neurodegenerative diseases (25–28).
The cause of musician’s dystonia is obscure, but certainly
seems multifactorial with different factors more important in
different persons. The settings in which it most often develops
involve repetitive performance of a movement that requires great
skill. This setting implies the disorder is acquired due to certain
environmental factors. While there are some genetic studies that
have linked musician’s dystonia in the arm and writer’s cramp
with variants in the arylsulfatase G gene, it remains unclear how
genetics, environmental influences, and their interactions result
in the development of the disorder (29). Classically considered to
be an irreversible phenomenon, recent work has raised the possibility that early identification of patients and prompt initiation of
treatment might rescue some patients, allowing them to continue
their performing careers (30).
Although it is often claimed that 10–15% of patients with idiopathic Parkinson’s disease may present with focal dystonia of the
upper or lower limb, especially in early-onset cases, surprisingly
few studies report the prevalence of this phenomenon, or of the
clinical characteristics, that help to distinguish these cases from
non-degenerative adult-onset focal limb dystonia (31, 32). The
paucity of large clinical studies comparing the clinical features
distinguishing the limb dystonias of degenerative Parkinsonrelated disorders from the limb dystonias of non-degenerative
adult-onset isolated focal dystonias likely contributes to frequent
misdiagnoses. Indeed, multiple studies have described patients
with isolated limb dystonia who were misdiagnosed as having
Parkinson’s disease (33–36).
Some patients exhibit semi-rhythmical movements of the
hand and arm, with little or no postural abnormality. When
these movements occur only with writing, they are often called
primary writing tremor. It remains controversial whether these
types of abnormal movements should be classified as a subtype of
dystonia (e.g., dystonic tremor), as a subtype of essential tremor,
or as a distinct entity (37–44). Without a reliable biomarker for
either dystonia or essential tremor, the exact classification will
remain a matter of debate.

Table 1 | Limb dystonia by etiology.
Isolated: dystonia
is the only motor
feature

Combined:
dystonia is
combined with
other movement
disorders

Adult-onset
task-specific

• Writer’s cramp
• Musician’s dystonia
• Runner’s dystonia

Adult-onset non-taskspecific limb dystonia

• Idiopathic

Adult-onset non-taskspecific limb dystonia

• Parkinson disease
• Atypical parkinsonian disorder
(i.e., corticobasal degeneration)
• Posttraumatic or complex
regional pain syndrome
• Psychogenic

Dystonia-plus
syndromes

• Dopa-responsive dystonia
• Rapid-onset dystonia
parkinsonism
• Myoclonus-dystonia syndrome

Paroxysmal dyskinesia
and dystonia

• Paroxysmal kinesigenic dystonia
• Paroxysmal non-kinesigenic
dystonia
• Paroxysmal exercise-induced
dystonia

Heredodegenerative
dystonia

• Wilson’s disease
• Huntington’s disease
• Neuroferritinopathy

Structural lesions

• Stroke
• Tumor

between 1 and 2% of musicians (15, 16). The hand that performs
the more complex motor task appears to be preferentially affected
(e.g., right hand in pianists, left hand in violinists, right hand in
guitarists) (13). Musician’s dystonia can be encountered with
essentially all musical instruments, but certain instruments are
overrepresented in clinical series of musician’s dystonia, such
as keyboard, guitar, and violin. The age at initiation of musical
instruction appears to influence risk for development of the
disorder, with instruction before age 10 being protective against
the development of dystonia.
Typically musician’s dystonia of the hand and arm begins as
an insidious deterioration in previously automatic performance,
followed by involuntary posturing within months of symptom
onset (17). Dystonia may affect the fingers, wrist, upper arm,
and even the shoulder girdle. Frequently, the pattern of dystonia
segregates with certain instruments, for example adjacent finger
flexion in pianists, wrist flexion in percussionists, and shoulder
girdle involvement in the bow arm of violinists.

Current Knowledge Gaps and Areas of
Controversy in Upper Limb Dystonia

The epidemiological studies of upper limb dystonia are widely
believed to underestimate true prevalence rates, because many
cases go unrecognized for many years or they are misdiagnosed
as more common conditions, such as repetitive injury syndromes,
Parkinson’s disease, or tremor. One of the most common forms of
task-specific dystonia is dystonic writer’s cramp, but the prevalence
of this form of focal dystonia has not been studied. In fact, one study
revealed an average latency of more than 10 years from symptom
onset to diagnosis for upper limb dystonias (18). Furthermore,
agreement on diagnosis for upper limb dystonias is modest, even

Frontiers in Neurology | www.frontiersin.org

Dystonia of the Lower Limb

Focal or segmental dystonia confined to the lower limb is an
uncommon focal dystonia and requires a meticulous assessment
and testing to exclude other conditions, such as parkinsonism,
stiff-person syndrome, and other movement disorders (45, 46).
Runner’s dystonia (RD), an important but often undiagnosed or
misdiagnosed type of lower limb dystonia, is defined as a taskspecific focal or segmental dystonia of the lower limb or trunk
triggered by running (47). Patients with RD often describe their
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features such as task specificity and the use of sensory tricks can
be seen in lower limb dystonia, similar to other forms of dystonia. The relationship between isolated leg dystonia and other
neurodegenerative diseases (i.e., Parkinson’s disease) is not well
understood.

initial symptom as a subtle change in their gait or running stride,
a limp or a sense of pulling, cramping, or stiffness triggered by
running and improved with rest. At first, they often attribute their
symptoms to overuse, a change in shoes or a different running surface. They may also suspect “foot drop,” an injury (muscle strain/
sprain), or other musculoskeletal complaint (48). Commonly
reported symptoms in RD include a limp when running, dragging of the foot or leg, inversion of the foot, scuffing of the toe,
clipping an ankle with the opposite foot, trunk tilt, and/or pain.
Similar to other focal dystonias, patients with RD may report an
alleviating maneuver (also referred to as “geste antagoniste” or
“sensory trick”), which improves their symptoms (49, 50).
When symptoms persist or worsen, a patient commonly selfrefers to an athletic trainer/coach, physical therapist, sports medicine, or orthopedic physician—delaying the correct diagnosis
often by many months or even by years (51). A missed diagnosis
may also lead to unnecessary therapies and/or invasive procedures
(52). By the time a patient with RD consults with a movement disorder specialist, their symptoms have often generalized to involve
walking, and running may be limited or impossible. A possible
clinical clue to the diagnosis of RD is a marked improvement in,
or complete absence of, symptoms when the patient walks or runs
backwards (i.e., task specificity).
Assessment of patients with suspected RD includes a history
and physical examination with special attention to the musculoskeletal and neurological systems. The differential diagnosis of
RD includes a focal dystonia presenting as the initial symptom
of primary generalized dystonia, a secondary process (stroke,
Parkinson’s disease), trauma, and functional (psychogenic) causes
(45, 53, 54). If not previously performed, the diagnostic work up
may include electrodiagnostic testing, spine/brain/skeletal imaging, and laboratory studies including metabolic and, potentially,
genetic testing. Functional assessment in RD includes observational and videotaped assessment of the patient at rest, standing,
walking, and running. Video assessment may reveal subtle findings that are missed during real-time observation and can be used
to evaluate the response to an intervention.
When RD is suspected and questions remain about the diagnosis
after history and clinical exam, 3D computerized motion analysis
may provide useful information about which muscles are involved.
This method may help identify specific causes for this difficulty and
guide treatments (55). Careful analysis of the electromyography
(EMG) data is required paying special attention to the timing and
duration of muscle activation, the relationship to kinematics, and
side-to-side comparison. Abnormalities of muscle activation in
patients with dystonia include onset, timing, duration, magnitude
of recruitment, depression or prolongation of phasic bursts, and
co-contraction; however, no studies have proven these tests to be
diagnostic. Other abnormalities considered to be consistent with
dystonia include activity at rest, an inability to relax when a movement ends, and overflow to an unwanted body part.

Key Research Priorities in Clinical
Features of Upper and Lower Limb
Dystonias

• Development of clinical diagnostic criteria for upper and
lower limb dystonias, taking into consideration their clinical
heterogeneity
• Clarify the relationship between dystonia, tremor, and dystonic tremor
• Clarify the relationship between dystonia and mirror dystonia
• Systematic characterization of clinical characteristics of
patients presenting with isolated limb dystonia who are likely
to progress to Parkinson’s disease or a related degenerative
parkinsonian condition
• Characterize the genetic and environmental influences on the
development of musician’s dystonia

Posttraumatic Dystonia, Peripherally
Induced Dystonia, and Complex Regional
Pain Syndrome (CRPS)

Central (brain) trauma has been long recognized as a cause of
dystonia, but peripherally induced dystonia, triggered by trauma
to the cranial or peripheral nerves or roots, is still controversial
(56). In a review of 190 articles presenting findings on 596
patients with peripherally induced movement disorders, the
most frequently reported movement disorder was dystonia
(74%), followed by tremor (23%), myoclonus (15%), spasms
(11%), painful limbs moving extremities (6%); and another 2%
had parkinsonism, chorea, and tics (57). Most studies reported
latencies of less than 1 year (median = 21 days), but in 27 cases
(5%) the reported interval between injury and the onset of movement disorder was greater than 1 year. Only 170 patients (29%)
showed evidence of a nerve injury. Pain was an important feature
in the majority of patients (81%) and preceded the onset of movement disorder in 20% of the cases. CRPS was diagnosed in 42%
of the reported cases but only 8% had nerve injury. BoNT was
the most frequently applied therapy (21%) in this review, with
57% of patients treated with BoNT reporting mild or moderate
improvement in symptoms. Physical therapy and oral medications, such as trihexyphenidyl, baclofen, and muscle relaxants,
provide only limited benefit in this population. Due to a concern
of abnormal sympathetic drive in this disorder, chemical and surgical sympathectomies have been used in this patient population,
but due to common complications after sympathectomy and lack
of evidence of clear long-term benefit, it is now rarely used (58).
Deep brain stimulation (DBS) has been only rarely reported to
be beneficial in patients with peripherally induced dystonia (59).
Despite strict diagnostic criteria, including the requirement
for anatomically and temporally related injury, the cause-andeffect relationship between the peripherally induced injury and
subsequent movement disorder may not be obvious in all cases.

Current Knowledge Gaps and Areas of
Controversy in Lower Limb Dystonia

Lower limb dystonia is less common than other focal dystonias,
such as cranial and cervical dystonias, but its true prevalence
is not known and is likely currently underestimated. Clinical
Frontiers in Neurology | www.frontiersin.org
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Although the pathophysiological mechanisms of peripherally
induced movement disorders are not well understood, emerging
evidence suggests that individual (e.g., genetic) predisposition,
coupled with central reorganization in response to the altered
peripheral input, plays an important role in the pathogenesis
of peripherally induced movement disorders (Figure 1). Arm
immobilization, a form of peripheral injury, can lead to decreased
thickness in the contralateral primary motor and somatosensory
cortical area and a decrease in the white matter fractional anisotropy in the contralateral corticospinal tract (60). Cortical
reorganization in the primary sensorimotor cortex occurs following arm amputation (61). Abnormal activation on functional
magnetic resonance imaging (fMRI) in regions such as the basal
ganglia and other brain regions reported in patients with CRPS
have not been confirmed by other studies (62). This may be partly
explained by heterogeneous population of patients, small sample
size, and methodological issues related to fMRI (63).

37% of the patients fulfilled diagnostic criteria for “documented
or clinically established psychogenic dystonia,” the authors concluded that “many patients fulfill strict criteria for a somatoform
disorder/psychogenic dystonia” and that fixed dystonia “usually,
but not always, occurs after a peripheral injury and overlaps with
CRPS” (64). Other studies have failed to establish direct connection between CRPS and an abnormal psychological profile
(65). Many patients with CRPS, however, share demographic and
clinical features with those diagnosed as functional (psychogenic)
movement disorders, such as female preponderance, young age,
and abrupt onset (64). Although no specific abnormalities in
brain structure or function have been consistently identified in
patients with CRPS, it would be premature to conclude that CRPS
is a functional (psychogenic) disorder (62).
In addition, there are other controversies concerning the
diagnosis and the pathophysiology of peripherally induced or
posttraumatic dystonia. Besides peripheral injury, prolonged
immobilization seems to be an important risk factor. One distinguishing clinical feature from other dystonias is the frequency
of pain as a presenting complaint. Although local injections of
BoNT into the muscle of the dystonic limb or an intradermal
injection in the region of the pain may improve the motor and
sensory aspects of CRPS-related dystonia, therapeutic options for
this disorder currently are limited and have not been systematically studied to date (66).

Current Knowledge Gaps and Areas
of Controversy in Peripherally
Induced Dystonia

One of the major sources of debate related to peripherally induced
dystonia is its possible relationship to functional (psychogenic)
movement disorders. This controversy is particularly highlighted
by the phenomenon of “fixed dystonia.” In the classic report by
Schrag et al., the authors described the clinical features of 103
patients presenting with fixed dystonia, primarily (90%) involving the limb (64). They followed 41 patients prospectively for a
mean of 3.3 years. In 63% of patients, the dystonia was preceded
by a peripheral injury and in 56% the dystonia spread to other
body regions. During the follow-up period, only 27% achieved
partial or complete remission. Pain was a major complaint in 41%
of the patients, and 20% met the criteria for CRPS. Although only

Key Research Priorities in Peripherally
Induced Dystonia

• Systematic clinical and neurophysiological characterization of
patients with peripherally induced dystonia compared to focal,
idiopathic limb dystonia, and to healthy controls
• Investigation of patients with pre-existing dystonia following
peripheral injury and/or immobilization using epidemiologic,
phenomenologic, neurophysiologic, and imaging studies to
identify any factors that might exacerbate underlying dystonia
to provide insights to peripherally induced dystonia
• Development of a suitable animal model that can explore the
effects of peripheral injury on spinal cord and brain and its
role in centrally mediated dystonic symptoms
• Design and conduct double-blind, controlled clinical trials
of BoNT in patients with peripherally induced dystonia to
establish the level of evidence that this treatment modality is
safe and effective in this population

PATHOGENESIS
Inhibition in Dystonia: Motor and Sensory

The pathophysiology of dystonia is characterized by a loss of inhibition, which has been shown at multiple levels in the nervous
system, from the spinal cord to the brainstem to the motor and
sensory cortical regions (67). This loss of inhibition manifests in
the periphery with abnormally long muscle bursts as measured
by EMG, co-contraction of agonist and antagonist muscles, and
overflow into adjacent muscles not needed for the particular
motor task (67).

Figure 1 | Diagram of hypothesis of peripherally induced movement
disorders.

Frontiers in Neurology | www.frontiersin.org
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Plasticity in Dystonia

Several measures of cortical excitability examined in focal
limb dystonia have revealed abnormalities including short
intracortical inhibition, mediated through GABA-A receptors,
and long intracortical inhibition, mediated by GABA-B (68).
Another measure of cortical excitability is the cortical silent
period (CSP). The CSP is a pause occurring during voluntary
movement after a pulse of transcranial magnetic stimulation
(TMS) is applied to the contralateral motor cortex. There are
both spinal cord and cortical inhibitory contributors to the CSP,
the latter likely mediated through GABA-B receptors (69, 70).
In writer’s cramp, the CSP is shortened compared to controls,
indicating an overall loss of inhibition in the motor system (71).
Interestingly, this finding has been seen only in the symptomatic
hand and not in the asymptomatic side. Further specificity was
seen in a study of writer’s cramp where the CSP was significantly
shorter in the patient group only during a pincer grasp but not
during a power grip condition, suggesting some task specificity in
this abnormality (72). During a pilot trial examining individualization of therapeutic repetitive TMS in two focal hand dystonia
patients, one of the response variables used was the CSP (73).
The investigators found that the subject with the shortened CSP
responded favorably to the repetitive TMS (rTMS) and had both
a physiological response with lengthened CSP and a subjective
clinical improvement (73).
While as noted above, the pathophysiology of focal dystonia
has generally shown a loss of inhibition, there are some examples
in the literature of enhanced inhibition in dystonia patients in
particular cortical pathways. A dorsal premotor to primary motor
cortex abnormality has been identified in writer’s cramp patients
at rest, where the writer’s cramp show enhanced inhibition compared to healthy controls (74). This inhibitory influence from the
premotor cortex (PMC) was found to be supraspinal in nature,
as the H-reflex did not change with premotor conditioning.
Evaluating this abnormal premotor–motor interaction through
a biomarker analysis showed an area under the curve of 0.825
with a sensitivity of 84% and specificity of 74% (74). Whether
this abnormality is a primary manifestation of the disease or is
a compensatory change is not clear, but a pilot trial enhancing
inhibition over the PMC in cervical dystonia has shown some
promise (75).
Abnormalities in inhibition in the sensory system have also
been identified in focal dystonia—specifically in the somatosensory temporal discrimination threshold (STDT). The STDT is the
shortest time interval necessary for a pair of tactile stimuli to be
perceived as two (76). STDT has been shown to be abnormal in
dystonia, including focal hand dystonia (77, 78) and in cervical
dystonia (79). However, abnormalities in STDT are not specific
for dystonia as they may be seen in other patient populations
(e.g., Parkinson’s disease) (80). The pathophysiology of abnormal STDT has been demonstrated to be due to a loss of a short
latency inhibitory process (78). Using inhibitory non-invasive
neurostimulation, the STDT was increased in healthy volunteers
(81). This led to the clinical effect of overall decreased ability to
discriminate between paired inputs, suggestive of at least part of
the phenotype seen in dystonia. This may be an instructive tool
to improve our interpretation of abnormal STDT and recapitulate
part of the phenotype in a human “model.”
Frontiers in Neurology | www.frontiersin.org

Another theme that has emerged in the pathophysiology of focal
dystonia is aberrant cortical plasticity. One widely used method
to assess cortical sensorimotor plasticity is paired associative
stimulation (PAS). Repeated pairs of peripheral nerve stimulation, typically median nerve stimulation at the wrist, followed by
TMS of the motor cortex (M1) between 21 and 25 ms later, induce
cortical plasticity. This produces a spike-timing dependent, longterm potentiation (LTP)-like plasticity at the level of the M1, also
known as associative plasticity. Initial studies in patients with
writer’s cramp showed excessive plasticity with abnormal spread
of the induced plasticity to non-targeted muscles (82, 83). The
increased LTP-like plasticity extends to body parts unaffected by
dystonia. For example, patients with cervical dystonia, blepharospasm, and oromandibular dystonia, all had excessive plasticity
measured in their unaffected hand muscles (84).
The ability to regulate plasticity to keep excitability within a
useable range, known as homeostatic plasticity, is also impaired in
dystonia (85). In addition to examining motor cortical plasticity,
studies have also measured somatosensory-evoked potentials
and found increased LTP-like plasticity in the somatosensory
cortex in patients with focal hand dystonia (86). Taken together,
these studies lead to the attractive hypothesis that task-specific
hand dystonia is related to excessive plasticity, possibly due to
abnormal association between sensory input and motor output
with deficient homeostatic control (87).
It should be noted, however, that several studies did not find
increased sensorimotor plasticity in focal hand dystonia using
PAS, and the results from different studies have varied (88). Some
of these conflicting results may be due to the inherent variability
of the effects of PAS even in healthy subjects (89, 90). In addition, there is also variability in the PAS paradigms resulting in
differing times between median nerve stimulation and TMS (e.g.,
21.5 vs. 25 ms) (91). Other factors including the repetition rate,
the stimulus strength and the number of paired stimuli delivered,
the state of muscle activity, the time of the day, attention to the
stimuli, and genetic factors, all are important factors in measurements of plasticity (92). Another form of LTP-like cortical plasticity induced by intermittent theta burst stimulation, which does
not involve sensory input, showed abnormal plasticity but was
decreased rather than increased in focal hand dystonia (93). These
findings suggest that abnormal processing of sensory input may
underlie increased associative plasticity in focal hand dystonia,
but the direction of change is variable depending on the study
paradigm and the exact part of the sensorimotor cortex probed.
One way to understand the role of plasticity in dystonia is
through the relationship between associative plasticity and the
effects of DBS, a therapy used to treat generalized dystonia and
less often, focal dystonia. DBS targeting the globus pallidus interna
(GPi) decreases excessive associative plasticity in patients with
generalized dystonia (94). However, the time of the maximum
decrease in plasticity occurred before the subsequent, maximum
clinical improvement, raising the possibility that the reduction
in excessive plasticity may drive clinical improvement (94).
Moreover, in patients with generalized dystonia who had the DYT1
gene mutation, the degree of associative plasticity correlated with
the maintenance of clinical benefit after GPi DBS was turned off
6
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for 2 days (95). In these patients, associative plasticity seemed to
reflect an ability to store normal movements and to resist abnormal
signals from the basal ganglia even while the therapy was turned
off. Direct measurement of GPi activity during DBS implantation
has also provided evidence that short-term plasticity is abnormal
in dystonia patients, with impaired paired-pulse depression seen
(96). This and other studies suggest that the impaired inhibition
seen cortically in associative plasticity studies is also reflected at
the basal ganglia level in direct recordings (96–98).

cerebellum, and lateral and medial PMC. The motor program for
writing has also been studied and includes parts of the PMC and
parietal areas. A special area in the PMC concerned with writing
is Exner’s area—near and analogous to Broca’s area for speech. A
specific subset of the overlap between these two regions must be
responsible for writing with the dominant hand, the usual limb for
writing and, therefore, the body part at risk for the development
of dystonia. In an fMRI experiment to determine task-specific
activation, stronger activations in the left dorsal prefrontal
cortex, left intraparietal sulcus, and right cerebellum in writing
were found compared with all other tasks. Additionally, the left
anterior putamen was active at onset for all the tasks, but only
showed sustained activation during the right-hand writing. An
exploratory analysis showed clusters in the left ventral PMC and
inferior and superior parietal cortices that were only significantly
active for right-handed writing (101).
A similar experiment was conducted in patients with writer’s
cramp. The regions that were task-specific in the normal individuals were less active in patients. Moreover, the connectivity
between the parietal and premotor areas was less strong (102).
Hence, it appears that a specific parietal–premotor pathway was
malfunctioning. In some sense, this is not surprising. Individual
parietal–premotor pathways do seem specialized for specific
tasks. This has been demonstrated most clearly for a reach-tograsp movement, where there are separate pathways for each
component (103). Moreover, large lesions of either parietal or
premotor areas will cause apraxia with a loss of many skilled
movements (104). Thus, a task-specific deficit could arise from
the interaction of a pathway where a specific task was learned
together with excessive motor repetition of that particular task in
the setting of uncontrolled plasticity.

Task Specificity

One of the most fascinating features of limb dystonia is task specificity. This refers to the situation where dystonia is manifested
only during a single task or several closely related tasks, such as
in writer’s cramp and in musician’s dystonia (e.g., pianist’s cramp
is only manifested when playing the piano). Although more
common in the upper limbs, task-specific dystonia can also affect
the face (e.g., embouchure dystonia) and the leg (e.g., RD). As
discussed earlier, the dystonia appears to be triggered, at least in
part, by repetitive skilled action, and virtually any task can be
affected. At onset, the dystonia can be very highly selective; some
cases of writer’s cramp, for example, have begun with involvement
of only a few specific letters. Moreover, the dystonic posture can
be highly focal involving only one or two fingers. While many
patients with a task-specific dystonia remain with relatively
restricted involvement, the dystonia can spread to involve more
muscles, becoming segmental dystonia or even more generalized
dystonia. In some patients, the task specificity is gradually lost
with dystonia affecting more tasks or even appearing at rest.
Why does repetitive activity drive the development of a
task-specific dystonia? Much evidence suggests that repetition,
in-and-of-itself, is not the sole driver, but that it is the interaction of repetitive activity with multiple factors. One likely factor
is a genetic predisposition. Another is inherent biomechanical
abnormality of the hand (99). If the hand is anatomically abnormal, then the motor control program might require modification
in order to accomplish the intended motor task. Another critical
factor seems to be abnormal plasticity processes in the brain.
As noted above, good evidence suggests that patients with limb
dystonia have abnormal homeostatic mechanisms to control
the upper and lower bounds of plasticity as well as heightened
plasticity overall, which is widespread both anatomically as well
as within the different dystonia types (100). The abnormalities of
plasticity suggest an endophenotype, not necessarily the cause of
dystonia by itself, but predisposing to the development of dystonia. The combination of repetitive activity, heightened plasticity,
and failure of limiting plastic change may well be the particular
combination needed to drive the development of dystonia.
How is it possible to have a task-specific deficit? Considering
writer’s cramp, for example, motor control in the hand itself is
basically working since all actions except writing are done well.
Moreover, the motor program for writing remains intact since
writing can be done normally with other limbs, albeit somewhat
clumsily. Hence, task specificity arises just with the particular
conjunction of a specific limb with a specific task. The pattern
of brain activation with a specific body part is well established
with somatotopic involvement of the primary motor cortex,

Frontiers in Neurology | www.frontiersin.org

Functional Imaging of Limb Dystonia

Functional imaging in isolated limb dystonia has helped to identify underlying pathophysiologic mechanisms, as exemplified in
the previous section. Various functional neuroimaging methods
have been used with other goals in mind and include molecular
imaging focusing primarily on brain hemodynamics or changes
in dopaminergic pathways and fMRI of resting-state blood oxygen level dependent signals.
Positron emission tomography (PET) measures of regional
cerebral blood flow can identify local blood flow responses to various stimuli. The general strategy has been to measure blood flow
with the participant at rest in the scanner and then repeat the PET
measure during an activation procedure. Local changes in either
blood flow or metabolism reflect local neuronal activity or the
changes in activity of terminal fields projecting to that area (105).
Initial studies of brain responses to hand movements in people
with isolated upper limb dystonia revealed differences in blood
flow responses. However, differences in how someone with hand
dystonia and a control subject move the hand could substantially
confound interpretation of such studies. This methodologic ambiguity and the observation of sensorimotor integration problems in
people with hand dystonia led to studies of blood flow responses
to sensory driven stimuli.
Vibration of a hand produces a blood flow response in contralateral sensorimotor cortex and supplementary motor area.
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increasing data suggest that the dystonia also may reflect changes in
cerebellar function that may result from either direct involvement
of cerebellum by functional connections with other brain regions
or networks. Resting-state functional connectivity studies with
magnetic resonance imaging (rs fcMR) have demonstrated strong
functional connectivity in humans between striatum and a large
area extending from upper and middle brainstem into cerebellum
(119). These findings do not necessarily reflect direct anatomic
connections but evidence for direct connections in non-human
primates between the cerebellum and the subthalamic nucleus
via the pons (120). The cerebellar vermis also has direct connections to primary motor and premotor areas (121)—areas that also
have functional connectivity with the striatum. Thus, dysfunction
in a brain network, either precipitated by direct involvement of a
specific node or modulation at the network level, may provide the
underlying pathophysiology of limb dystonia.
In support of this notion, rs fcMR studies indicate reduced
functional connectivity between inferior parietal lobule and
dorsal PMC contralateral to right-handed writer’s cramp patients
(122). Another rs fcMR studied revealed increased functional
connectivity with the left putamen as a component of the default
mode network (DMN) in 16 people with right hand writer’s
cramp compared to controls. Although the putamen is not typically considered part of the DMN, a network that includes prefrontal, anterior and posterior cingulate, lateral parietal, inferior
and middle temporal area, cerebellar areas, and thalamus (123),
the comparison of the independent component containing the
DMN between the writer’s cramp and control groups revealed
this increased putamen functional connectivity (124). In this
same study, the writer’s cramp group had reduced functional
connectivity with the left PMC that was part of the sensorimotor
network. Both of these findings were affected by BoNT injections.
The advantage of these resting-state studies is that they are not
confounded by either behavioral changes during the scanning
sessions or performance differences that could differ between
those with limb dystonia and control groups.

People with isolated hand dystonia, including a subgroup with only
right-handed writer’s cramp, show an approximately 25% reduction in these blood flow responses (106, 107) similar to findings
in other isolated dystonias (108). The vibratory stimulus elicited a
cramp in some of the dystonic participants, but these participants
did not have a different blood flow response from those who did
not have cramping. The healthy controls who simulated a dystonic
posture during the vibratory stimulus had an increased, rather
than decreased blood flow response. Similarly, a patient with
dopa-responsive dystonia showed reduced blood flow response
to vibration that normalized after a dose of l-DOPA (109). This
observation suggested that the vibration-induced blood flow
responses could be influenced by dopaminergic pathways.
Positron emission tomography also can provide direct
measures of dopaminergic receptors with most studies finding a
reduction in D2-like dopaminergic receptors. MPTP, a neurotoxin
selective for dopaminergic neurons, when given via one internal
carotid artery in non-human primates, produces contralateral
transient limb dystonia followed by chronic parkinsonism
(110, 111). During the transient dystonic phase, striatal D2-like
receptor binding is reduced about 25–30% but then increased
several fold during early parkinsonism. The increased D2-like
receptor binding gradually returned toward normal. However,
mRNA selective for D2R (selective for D2R over D3R) revealed
no change whereas mRNA for D3R did increase coinciding with
the D2-like receptor changes (112). These findings presaged
studies in humans with isolated limb dystonia that revealed a
similar reduction in striatal D2-like binding in those with either
isolated, idiopathic hand, or cranial dystonia (113–115). In fact,
the site of change in the putamen seems to relate somotopically
to the part of the body involved (116). Some have used [11C]
raclopride as the D2-like radioligand. This particular radioligand
can be displaced by increased release of endogenous dopamine.
This characteristic has permitted measures of striatal dopamine
release in response to drugs or tasks. In particular, a finger-tapping task elicited less dopamine release (measured as a change in
striatal uptake of [11C]raclopride) in people with writer’s cramp
whereas a speech task in those same subjects yielded greater
striatal dopamine release (115). Key findings from these studies
is that striatal D2-like receptor binding is likely abnormal in limb
dystonia and changes in dopamine release may also occur.
The selectivity of these changes for specific D2-like dopamine
receptors remains unclear. PET measures with a D2 highly selective radioligand [18F]N-methyl benperidol (D2 ≫ D3 selectivity)
did not reveal any changes in people with either hand or cranial
dystonia (117). This suggests that the findings with less selective D2-like radioligands may reflect a change in D3 dopamine
receptors, which would be consistent with the observation in
MPTP-induced transient dystonia in monkeys (110–112); however, confirmation of this notion awaits development of a highly
selective D3 radioligand for PET. Nevertheless, D1-like dopamine
receptors appear to be normal in hand and cranial dystonia (118).
Thus, these studies indicate a change in dopamine receptors possibly due to a change in striatal D3 specific dopamine receptors
in dystonia patients.
At this point, the focus has been on neuroimaging findings that relate to changes in striatal function or activity. Yet,

Frontiers in Neurology | www.frontiersin.org

Current Knowledge Gaps and Areas
of Controversy in Dystonia Pathogenesis

The pathophysiology of focal limb and task-specific dystonia
is characterized by a loss of inhibition, impaired sensorimotor
integration, and aberrant cortical plasticity as seen through noninvasive neurostimulation studies. How precisely task specificity
emerges from these underlying neurophysiologic changes is not
known; but, factors such as an underlying endophenotypic trait of
abnormal plasticity combined with repetitive task-specific movement generated in a particular sensorimotor network—all appear
relevant. This issue is a key area to focus on moving forward in
order to clarify how plasticity abnormalities translate into the
clinical expression of dystonia. In addition, functional neuroimaging studies have revealed changes in dopaminergic pathways
in the striatum and altered striatal and cerebellar pathways in
dystonia patients. Together, these various findings suggest that
changes at the network level underlie limb dystonia and raise
questions about whether cortical–striatal–thalamo cortical
networks are really segregated from cerebellar–thalamic–cortical
networks. In particular, the relationship with the dopaminergic
8
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system in dystonia is intriguing and worthy of future exploration.
This includes further invasive and non-invasive paired-pulse
studies (such as in GPi DBS for dystonia). As mentioned earlier,
the relationship between isolated focal limb dystonia and posttraumatic, peripherally induced dystonia is unclear. There have
been several studies aiming to explore at this question. A recent
study looking at patients with a fixed hand posture and CRPS
compared to healthy controls found sensorimotor abnormalities potentially compatible with a psychogenic dystonia and in
contrast to findings found in isolated focal hand dystonia (125).
Identifying similarities and contrasts between the underlying
pathophysiology of these disorders will be helpful moving forward perhaps both in diagnosis and in treatment.

conditions responsive to BoNT therapy (134). Another area of
interest is the choice of toxin for specific indications. To date,
no Level I studies have been performed allowing a comparison
of available formulations for limb and task-specific dystonia.
Comparative studies have been conducted in blepharospasm and
cervical dystonia populations, but it is not clear to what extent the
results can be extrapolated to focal limb dystonia.
Regarding injection technique, accurate targeting of the
relevant muscles, and avoidance of toxin spread to adjacent
structures are clearly desirable. Little data are available, however,
on the best guidance tools among the available options. There is
some evidence that using a guidance method, such as EMG,
is superior in accuracy to anatomic guidance alone (135) but
it is not clear how this translates into efficacy. This issue of
efficacy has been studied in limb spasticity, comparing electrical
stimulation and ultrasound guidance (136, 137) but not in limb
dystonia. Studies are ongoing comparing guidance techniques in
this patient population (Clinical Trials identifiers NCT02334683;
NCT02326818), and more are needed.

Key Research Priorities in Limb
and Task-Specific Dystonia Pathogenesis

• Further studies to distinguish cause from effect in both physiology and imaging studies, so that attention can be directed to
the most relevant biological correlates of dystonia
• Development of a diagnostic battery using neurophysiologic
and imaging tests, including identifying whether one test will
be sufficient for all focal dystonias
• Identification of therapeutic targets
• Understand the variability and reproducibility of PAS and
other non-invasive measurement tools in healthy subjects and
dystonia patients and standardization of study protocols to
minimize variability across studies
• Determine how exactly abnormal plasticity affects the specific
parietal–premotor pathway and how this relates to spread of
dystonia beyond a particular task or limb

Rehabilitation Interventions for Limb
Dystonias

Given the sparse literature on the topic and the rarity of the disorder, there are no clinical practice guidelines on rehabilitation in
upper or lower limb dystonia. However, conventional rehabilitation methods, such as stretching, strengthening exercises, manual
therapy, and splinting programs, are frequently used in clinical
settings when patients are referred for physical or occupational
therapy. These therapies are also often tested as a control intervention or combined with other therapies in research investigating
efficacy of a novel intervention protocol (138–140).
In limb dystonia patient populations, investigators have
proposed various forms of intensive motor training to recover
voluntary motor control. These approaches have been frequently
explored in treatments of musician’s dystonia using the methods
known as “slow down therapy” and “sensorimotor retraining”
(141). Other approaches have prioritized the reorganization of
the cortical somatosensory map using methods, such as Braille
training (142, 143), “learning-based sensorimotor training”
(138, 139, 144), or prolonged immobilization of the affected limb
(this method is no longer used) (145, 146). Attempts to normalize
muscle activity to restore voluntary control using biofeedback,
vibration, or electrical stimulation have also been used (147–151).
Similar to constraint-movement therapy, a method often used in
stroke rehabilitation, some investigators have used motor practice
combined with constraining the unaffected joints with the goal
of decreasing compensatory movements (152, 153). Finally,
combining neuromodulation methods with motor training in
an attempt to normalize brain excitability and further improve
motor performance has been tried either with transcranial direct
current stimulation (tDCS) (154–156) or with rTMS (140).
Despite the different theoretical bases of the interventions,
when considered together, rehabilitation studies in limb dystonia
suggest positive outcomes (157–159). Significant improvements
have been reported in rating scales of dystonia severity, arm disability, quality of musical performance, and quality of life (140, 144,
153, 160, 161). Studies that focused on sensory reorganization have

THERAPY
BoNT for Treatment of Limb
and Task-Specific Dystonias

Botulinum toxin has a well-recognized role in the treatment of
limb and task-specific dystonias; although, the amount of Level I
evidence available is limited (126). Currently, three BoNT type A
formulations (onabotulinumtoxinA, abobotulinumtoxinA, and
incobotulinumtoxinA) are approved for upper limb spasticity
and only one, onabotulinumtoxinA, for lower limb spasticity
(127). None of these are approved, however, specifically for focal
limb dystonia.
Several randomized, double-blind, controlled studies in limb
dystonia have been performed investigating abobotulinumtoxinA
(128, 129) and onabotulinumtoxinA (130–132). When comparing these studies, outcome measures and populations enrolled
have marked variability. This highlights one characteristic of
focal limb dystonia that makes obtaining reliable data on efficacy
challenging. Standardized scales or outcome measures capturing
all types of task-specific or limb dystonia are lacking. In addition,
the very nature of task specificity makes it difficult to generalize,
and its clinical manifestation and prevalence tend to change with
occupational skills relevant to the era and to the particular society
(133). The impact on quality of life is very patient-dependent,
and treatment response is at times radically different from other
Frontiers in Neurology | www.frontiersin.org
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reported increase in sensory discrimination (138, 139, 142, 144).
Furthermore, improved motor performance in writing, gait, and
musical performance has also been reported (142, 153, 161, 162).
Limitations of the above studies are typical of small-scale trials
and include lack of control groups, blinding, or randomization.
It is also likely that the interventions tested were of insufficient
duration, considering that limb dystonia likely develops over a
long period of time. As the rehabilitation research in limb dystonia develops, it will be important to investigate comparative
effectiveness of interventions to understand which approach
holds the most promise and the neurophysiological mechanism
of effect. Given the nascent stage of rehabilitation research in
focal dystonias, full-scale clinical trials have yet to be conducted.
Thus, definitive statements cannot yet be made regarding efficacy
and clinical implementation of a particular methodology.
A major challenge of rehabilitation intervention studies in
general is determining an appropriate control and clearly specifying the interventions to improve reproducibility. The hallmark
of rehabilitation is that it involves active participation by the
patient and is tailored to each patient’s unique need, which can
create problems for reproducibility. For a control to be effective, it
must be believable as a true intervention but not contain the key
components of the experimental condition. Indeed, blinding and
control are essential for future studies, as care from a therapist
may impart benefits secondary to feeling cared for in addition
to a pure placebo effect. Consequently, future investigations in
dystonia need to carefully address this issue by comparing different treatment strategies with similar frequency, duration, and
interaction between patient and therapist.
Study designs in a rare and heterogeneous disorder, such as
dystonia, require careful consideration outside of the gold standard multisite, randomized controlled trial. Small-scale trials are
appropriate given our limited understanding. However, studies
should utilize robust small n methodology such as single subject
experimental design studies with repeated measures (163).

stimulation targeting the contralateral hemisphere to the dystonic
hand. Siebner et al. found that M1 stimulation modestly improved
focal hand dystonia (168); however, Murase et al. showed that
PMC was a better target than M1 and supplementary motor area
to reduce writer’s cramp symptoms (169). Subsequently, more
studies used PMC as the target in multi session interventions
and showed promising results either by physiologic or behavioral
measures (170, 171). rTMS combined with sensorimotor retraining did not provide objective improvements in patients despite
subjective improvement in six of nine (73). The results of these
small-scale clinical trials with low-frequency rTMS have been
mixed, and it is not currently ready for clinical application in this
population.
In the last years, tDCS has gained popularity, partly due to its
simple application combined with its low cost and low risk for
adverse events. In patients with musician’s dystonia (e.g., professional guitarists), a single session of cathodal tDCS targeting the
affected M1 did not improve the performance of guitar playing
(172). Similarly in pianists, a single session of cathodal or anodal
tDCS of the affected M1 combined with simultaneous retraining
consisting of slow, voluntarily controlled movements on the piano
did not result in any improvement in dystonia (173). The same
strategy did not help patients with writer’s cramp (174). In contrast,
cathodal tDCS of the affected M1 and simultaneous anodal tDCS
of the unaffected M1 in dystonic pianists improved the rhythmic
accuracy of sequential finger movements with the affected hand,
but only if concurrent bimanual mirrored finger movements were
performed (155). This improvement lasted for 4 days after the
intervention. Neither a reversed montage of electrodes (anodal
tDCS of the affected M1, cathodal tDCS of the unaffected M1)
nor unilateral anodal tDCS of the unaffected M1 or sham stimulation yielded any improvement (155). Furthermore, the amount of
motor improvement correlated directly with the severity of the
symptoms, that is, the most severely affected patients benefited
most from the intervention. These findings suggest therapeutic
potential in behavioral training assisted by bihemispheric and
polarity-specific tDCS in restoring fine motor control in musician’s
dystonia. A further single-case study showed augmented therapeutic effects through bihemispheric tDCS combined with bimanual
mirrored retraining over two successive days (175). Another group
explored biparietal tDCS during neurorehabilitation and showed
improvement in dystonia severity in musicians (156).

Non-invasive Brain Stimulation
and Hand Dystonia

Non-invasive brain stimulation techniques, such as rTMS and
tDCS, have been applied in both basic research into the pathophysiology of hand dystonia and in therapeutic trials (164). Both
methods can alter brain excitability in sensorimotor networks,
which can be used to reduce abnormal excitation in sensorimotor
cortex. The precise neurophysiological mechanisms underlying
this change in excitability are not fully understood; however,
high frequency rTMS and anodal tDCS are able to increase excitability of the sensorimotor cortex (165). Low-frequency rTMS
and cathodal tDCS achieve excitability changes in an inhibitory
direction (165). The effects of non-invasive neurostimulation are
far more complex than unidirectional excitability change and are
not limited to the site of the stimulating electrodes but extend to
frontal and parietal networks as well as to the basal ganglia and
to the cerebellum (166, 167).
Several small controlled therapeutic trials of writer’s cramp
have been done with inhibitory low-frequency rTMS (164).
Studies typically included less than 10 mostly writer’s cramp
subjects and most used a crossover design with a single session of
Frontiers in Neurology | www.frontiersin.org

DBS and Limb Dystonia

Deep brain stimulation targeting GPi is a highly effective treatment for medically refractory isolated generalized dystonia,
supported by high quality case series and randomized controlled
trials (176). Patients with cervical dystonia who respond neither
to medications nor targeted injections of BoNT may also benefit
from DBS, but less reliably so (177). In contrast, the experience
treating focal limb dystonia with DBS is quite sparse, most likely
because this form of dystonia is uncommon and rarely debilitating, so that the potential risks of DBS surgery seem unwarranted.
On the other hand, task-specific dystonias may force an individual to forego an activity that makes his or her life meaningful
and BoNT injections can yield significant weakness in both the
treated and adjacent muscles, denying the individual the fine
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• Non-invasive brain stimulation: future trials to take into consideration the dose and duration of stimulation protocol, predictive markers for responders, designs which allow between
and within subject effects to be explored and combination
with specific motor retraining procedures
• Invasive brain stimulation: design randomized controlled
trials with good subject characterization
• Identifying the triggering movement, and differentiating
primary vs. compensatory movements is critical for selection
of the best muscles for BoNT injection in musician’s dystonia
• Development of an effective therapeutic strategy including
early identification of patients, prompt initiation of treatment
as well as new and better therapies, and modification of the
“every three months” BoNT injection paradigm to fit the
schedule and needs of a performing artist

motor skills required to perform the practiced task despite relief
of their abnormal dystonic posture.
A review of the literature regarding stereotactic surgery for
focal limb dystonias reveals the following: (1) fewer than 50
patients who have undergone a brain surgery for either writer’s
cramp or musician’s dystonia are reported in the literature; (2) all
of these patients were operated in either Korea or Japan; (3) the
majority were treated with ventralis oralis thalamotomy, the rest
with thalamic DBS; and (4) the results were uniformly positive,
though assessed in an un-blinded fashion with relatively short
follow-up (178–181). There is virtually no literature regarding the
use of pallidal surgery (ablation or DBS) for focal limb dystonia.
Given these reported results, the fact that DBS is a safe intervention in skilled hands (incidence of serious neurologic injury:
1–2%), and the opportunity to address an unmet need with
this targeted intervention, it would seem that a more rigorous
evaluation of thalamic DBS for focal limb dystonia is appropriate.
However, the small but real risk of catastrophic stroke/hemorrhage
and the fact that focal limb dystonia is neither life-threatening
nor always debilitating, mandate that these studies be conducted
at comprehensive movement disorders centers that include both
an experienced DBS surgeon with a documented low surgical
complication rate and neurologists facile both in the treatment of
focal limb dystonia and the programming of DBS devices.

Table 2 | Themes in focal limb dystonia research priorities.
Diagnosis

• Upper limb
• Lower limb
• Peripherally induced

Standardize
neurophysiologic tests

• CMA
• Paired associative
stimulation (PAS)

Development of
• Somatosensory temporal
discrimination threshold
diagnostic battery using
• Functional magnetic resonance
neurophysiology and
imaging tests
imaging

Current Knowledge Gaps and Areas
of Controversy in Therapy in Focal
Limb Dystonia

Phenotypic
characterization

Botulinum toxin therapy is often applied in an off-label manner
in focal limb and task-specific dystonia but only limited evidence
supports this practice due to the heterogeneity of the condition
and to a lack of standardization in practice and data collection.
Despite limitations, studies of rehabilitation in limb dystonias,
as well as anecdotal reports, suggest a potential for improved
outcomes for patients with rehabilitation intervention delivered
by a therapist trained in the unique needs of a patient with
dystonia, but definitive efficacy of a specific approach remains to
be demonstrated. Non-invasive (rTMS and tDCS) and invasive
(DBS) therapeutic modalities have been explored in only a small
number of limb and task-specific dystonia patients and in studies with design limitations, which hampers the ability to move
forward currently to larger clinical trials and to expand these
potential therapies into clinical practice.

Isolated focal limb
dystonia

• Relationship to neurodegenerative
disease

Peripherally induced
dystonia

• Identify factors that are protective
or promoting

Tremor, dystonia,
dystonic tremor

• Clarify the relationship of tremor
with dystonia

Genetic and
environmental
influences

• Isolated limb dystonia and taskspecific dystonia

Pathophysiology Loss of inhibition

Key Research Priorities in Therapy
in Focal Limb Dystonia

Therapy

• BoNT: refine the role of BoNT therapy by optimizing practice, developing new formulations, and use of combination
therapeutic modalities (such as BoNT combined with physical
therapy or neuromodulation)
• Rehabilitation: determine appropriate controls, understand the
neurophysiological effects of rehabilitation for limb dystonias,
determine best frequency and duration for interventions given
that a long period of time likely is required for symptom development, determine duration of benefits after rehabilitation
interventions
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Development of
diagnostic criteria
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• Understand how a loss at a
network level translates to a focal
symptom

Abnormal plasticity

• Understand the variability in PAS
response

Task specificity

• Understand the relationship
between repetition and abnormal
plasticity

Peripherally induced,
posttraumatic

• Understand commonalities and
differences between isolated
dystonia and posttraumatic

Clinical trial
development

• Innovative designs with small n
• Duration of therapy needed for
a disease that took years (or
decades) to develop
• Harness the inter-patient
variability
• Standardize outcome measures

Development
of therapeutic
targets for invasive
and non-invasive
neurostimulation

• Target localization for all focal
limb dystonias
• Systematic assessment of
duration and stimulation
parameters
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SUMMARY

also provided by the Dystonia Medical Research Foundation.
Travel grant support was provided by Beat Dystonia, the Benign
Essential Blepharospasm Research Foundation, Cure Dystonia
Now, the Dystonia Medical Research Foundation, and the
National Spasmodic Dysphonia Association.

Focal limb dystonias, from the task-specific to the peripherally
induced, share clinical features with the other focal dystonias
such as the adult-onset nature of the disease and the presence
of sensory tricks that can temporarily ameliorate dystonic
symptoms. However, the focal limb dystonias have a clinical
heterogeneity (e.g., pianists dystonia and RD), which makes
design of studies complicated from choosing specific anatomical
targets for therapeutic interventions to developing comprehensive outcome measures that can fully quantify change in
symptoms given high variability at baseline (Table 2). Focus on
the research priorities as outlined here aims both to advance
diagnostic capabilities and knowledge of the pathophysiology
of this disorder, but also, to develop innovative therapeutic
strategies to keep focal limb dystonia patients writing, running
and performing.
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